• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG M.BLUE PLUS SYS W/CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG M.BLUE PLUS SYS W/CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX824T
Device Problems Mechanical Problem (1384); Infusion or Flow Problem (2964)
Patient Problem Hydrocephalus (3272)
Event Date 11/08/2023
Event Type  Injury  
Manufacturer Narrative
Investigation: visual inspection during the investigation, scratches on the outer housing of the valve, but no significant deformations or damage was determined.Permeability test a permeability test has indicated that the m.Blue valve is permeable.Computer controlled test to investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valve is tested in both the horizontal as well as the vertical positions.The results show that the m.Blue is operating within the accepted tolerance in the horizontal position, but not within the specified tolerances in the vertical position.An accelerated outflow of m.Blue could be determined.Adjustment test the m.Blue valve was tested and is partially adjustable (from 22 to 24 cmh2o).Braking force and brake function test the brake functionality test has shown that the brake function is operational, however the braking force cannot be measured due to the limited adjustability of the valve.Internal inspection after dismantling of the valve, deposits were found in m.Blue.Results based on our investigation results, we can determine an accelerated outflow in the valve.The determined deposits can be named as the cause for the accelerated outflow.Proteins in the cerebrospinal fluid can influence the function temporarily and are known side effects in hydrocephalus therapy.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Event Description
It was reported that a m.Blue (#fx824t) was implanted during a procedure performed on (b)(6) 2023.According to the complainant, the shunt system was believed to be operated in under-drainage and adjustment difficulties.The patient underwent a revision procedure.The complainant device was returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 12 years height: 135 cm weight: 35 kg gender: female.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
M.BLUE PLUS SYS W/CONTROL RESERVOIR
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key18312219
MDR Text Key330295204
Report Number3004721439-2023-00362
Device Sequence Number1
Product Code JXG
UDI-Device Identifier00401906504830
UDI-Public401906504830
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K192266
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFX824T
Device Catalogue NumberFX824T
Device Lot Number20052916
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/13/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/13/2023
Initial Date FDA Received12/12/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/30/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age12 YR
Patient SexFemale
Patient Weight35 KG
-
-